Abstracts Topics
|
✔ |
Addressing the Global CV Risk Factors in Pre-Disease and in Disease |
✔ |
The Heart, the Brain and the Kidney in Pre-Disease and the Metabolic Syndrome |
✔ |
Arterial Properties, Central Blood Pressure and Augmentation Index in Pre-Disease and Disease in Patients with Cardiometabolic Syndrome |
✔ |
PreHypertension and Metabolic Syndrome in Different Populations – Epidemiologic Aspects |
✔ |
Arterial Properties, Evaluation and Treatment in Metabolic Syndrome |
✔ |
Prediabetes – Mechanisms, Diagnosis and Management |
✔ |
Benefits of Achieving Optimal Risk Factors Level – When, How and with What? |
✔ |
PreHypertension, Hypertension and Renal Denervation |
✔ |
Cardiometabolic Syndrome in Children |
✔ |
Metabolic Syndrome and Vitamin D |
✔ |
Children and Adolescents: PreHypertension and Metabolic Syndrome, Progression of Risk and Diagnosis of Disease |
✔ |
PreHypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach |
✔ |
Effect of Pre-Disease Risk Factors in Patients with the Metabolic Syndrome on Morbidity and Mortality |
✔ |
Which Elderly Patients with Pre-Disease should be Considered for Medical Treatment |
✔ |
Gestational Prehypertension and Gestational Hypertension |
✔ |
Total Cardiovascular Risk Evaluation and Management |
✔ |
Cardiac Markers of Pre-Clinical Disease in Metabolic Syndrome Patients |
✔ |
Pre-Levels of CV Risk Factors – Boosting Risk of Events and Deciding Who Should be Treated |